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Abstract: Warburg’s hypothesis has been challenged by a number of studies showing that 
oxidative phosphorylation is repressed in some tumors, rather than being inactive per se. 
Thus, treatments able to shift energy metabolism by activating mitochondrial pathways 
have been suggested as an intriguing basis for the optimization of antitumor strategies. In 
this  study,  HepG2  hepatocarcinoma  cells  were  cultivated  with  different  metabolic 
substrates  under  conditions  mimicking  ―positive‖  (activation/biogenesis)  or  ―negative‖ 
(silencing)  mitochondrial  adaptation.  In  addition  to  the  expected  up-regulation  of 
mitochondrial  biogenesis,  glucose  deprivation  caused  an  increase  in  phosphorylating 
respiration and a rise in the expression levels of the ATP synthase β subunit and Inhibitor 
Factor 1 (IF1). Hyperglycemia, on the other hand, led to a markedly decreased level of the 
transcriptional coactivator PGC-α suggesting down-regulation of mitochondrial biogenesis, 
although  no  change  in  mitochondrial  mass  and  no  impairment  of  phosphorylating 
respiration were observed. Moreover, a reduction in mitochondrial networking and in ATP 
synthase  dimer  stability  was  produced.  No  effect  on  β-ATP  synthase  expression  was 
elicited. Notably, hyperglycemia caused an increase in IF1 expression levels, but it did not 
alter the amount of IF1 associated with ATP synthase. These results point to a new role of 
IF1 in relation to high glucose utilization by tumor cells, in addition to its well known 
effect upon mitochondrial ATP synthase regulation. 
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1. Introduction 
The most popular paradigm of metabolic remodelling describing the occurrence in tumor cells (the 
Warburg effect) comprises an increase in glucose uptake, an enhancement of glycolytic capacity, high 
lactate production, and the absence of respiration (despite the presence of high oxygen concentrations) 
caused by irreversible damage to mitochondrial function [1]. Over the last decade, this ―metabolic 
dogma‖  has  been  re-evaluated  in  light  of  various  bioenergetic  studies  that  have  emphasized  the 
variability existing between and even within cancer types as regard to the mechanisms and substrates 
preferentially used for deriving vital energy [2]. Nowadays, Warburg’s ―aerobic-glycolysis‖ hypothesis 
has been challenged by a growing number of studies, showing that mitochondria, in some tumor cells, 
are  not  inactive  per  se,  but  operates  at  low  capacity,  repressed  by  the  presence  of  glucose, 
demonstrating the importance of a dynamic view of tumor bioenergetics [3]. 
Several  mechanisms  that  directly  promote  the  inhibition  of  mitochondrial  function  have  been 
proposed,  even  if  the  molecular  basis  of  this  phenomenon  is  still  unknown  [4].  Moreover,  it  has  
been  demonstrated  that  some  tumor  cell  lines  can  switch  from  aerobic  glycolysis  to  oxidative 
phosphorylation (OXPHOS) under glucose-limiting conditions [5–8] via alterations in the morphology 
of  the  mitochondrial  network  and  the  up-regulation  of  mitochondrial  mass  and  respiratory  chain 
protein  expression  levels.  It  has  also  been  demonstrated  that  cancer  cells  behave  differently  
to  normal  cells  when  adapting  their  bioenergetics  to  microenvironmental  conditions  (hypoxia  and 
aglycemia) [6,9]; thus, this difference in the tolerance of cancer cells to their environments could be 
important for optimizing anti-cancer treatment strategies. Indeed, a recent review discussed how the 
pharmaceutical intervention of cellular energy metabolism could render tumor cells more susceptible 
to  anti-cancer  treatments  [4];  different  possibilities  were  indicated  depending  on  the  predominant  
ATP-generating  pathways  concerned.  In  addition  to  the  well  known  suppression of  the  glycolytic 
pathway, it has been proposed that shifting a cell’s metabolism to glucose oxidation may reverse the 
glycolytic phenotype, thereby restoring the cell’s sensitivity to apoptotic inducers and opening up 
another  effective  therapeutic  strategy.  Recently,  it  was  reported  that  the  overexpression  of  the 
mitochondrial  frataxin  protein  [10]  or  attenuation  of  lactate  dehydrogenase  A  [11]  increases 
mitochondrial energy metabolism in tumor cell lines, resulting in the suppression of tumor growth. In 
conclusion,  understanding  the  molecular  mechanisms  involved  in  the  bioenergetic  mitochondrial 
adaptation/silencing of tumor cells and the limits of this phenomenon is of fundamental importance for 
defining  this  form  of  plasticity  and  for  understanding  tumor  tolerance  to  changes  in  nutrient 
composition. This is especially the case when considering that different mitochondrial backgrounds 
may confer a survival advantage to tumors cells in response to chemotherapy [12]. 
In this study, the human hepatocellular carcinoma cell line HepG2 was used; the mitochondrial 
bioenergetic profile of which has already been characterized with regard to its differentiation/growth 
tumor grade [13]. Cells were cultivated in the presence of different concentrations of glucose with the Int. J. Mol. Sci. 2012, 13  1935 
 
 
aim of inducing ―positive‖ mitochondrial plasticity in aglycemia conditions, as well as ―negative‖ 
adaptation  to  hyperglycemia.  This  strategy  was  based  on  the  knowledge  that  high  glucose 
concentrations are involved in the silencing of mitochondria in tumors, whereas glucose deprivation is 
involved  in  their  activation/biogenesis.  The  study  focuses  on  the  effects  of these  conditions  upon  
(i) ATP synthase, as the impact of metabolic adaptation on the supramolecular organization of ATP 
synthase has not yet been described; and (ii) Inhibitor Factor 1 (IF1), since it has now been recognized 
that IF1 function is not limited to its role as the physiological inhibitor of ATP synthase, but that it also 
constitutes a key component in the metabolic switch of tumor cells [14–16]. 
2. Results and Discussion  
2.1. Cell Proliferation and Mitochondrial Content/Biogenesis  
Cell  proliferation  rates  (i.e.,  doubling  times)  of  HepG2,  grown  in  the  three  different  culture 
conditions, were compared. HepG2 cells divided faster in the high glucose (25 mM) medium (doubling 
time: 19 ±  0.8 h) than in the intermediate (11 mM) glucose condition (doubling time: 30.7 ±  0.5 h). In 
galactose medium, the doubling time was approximately two times longer (50 ±  1.2 h). No significant 
change  in  cell  morphology  or  cell  viability  was  observed  in  HepG2  grown  under  the  three 
different conditions. 
Cell  mitochondrial  contents  were  evaluated  by  estimating  the  protein  recovery  in  the  crude 
mitochondrial fractions and are reported in Figure 1a. We documented a higher mitochondrial content 
in HepG2 cultivated in 10 mM galactose with respect to that observed when the cells were cultivated 
in medium with 11 mM or 25 mM glucose, both of which were similar. This difference was further 
validated in evaluating the mitochondrial mass by assaying CS activity in total cell homogenates. The 
results, reported in Figure 1b, confirm a significant increase in mitochondrial content of HepG2 grown 
under aglycemic conditions.  
We  also  determined  the  expression  level  of  a  key  regulator  of  mitochondrial  biogenesis,  the 
peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α), by Western blot analysis on cell 
lysates. The results, shown in Figure 1c, indicate an increase in the expression level of PGC-1α in 
HepG2 grown in 10 mM galactose as compared with cells grown in 11 mM glucose, whereas a marked 
significant decrease was seen in cells grown in 25 mM glucose. 
The results obtained for HepG2 cells grown in the absence of glucose prove that mitochondrial 
biogenesis was stimulated and resulted in an increase of mitochondrial mass, probably in order  to 
compensate for the diminished supply of glycolytic ATP—they are in accordance with data obtained 
by Weber and colleagues using the same cell line [8]. On the contrary, in the hyperglycemic condition, 
evidence is  provided  here  for  the  silencing  of  transcriptional  regulatory  proteins  of  mitochondrial 
biogenesis, without any change in mitochondrial mass.  
In agreement with these results, the long-term exposure of HepG2 to a high glucose condition has 
previously been demonstrated to cause a decrease in mitochondrial content and biogenesis [17].  Int. J. Mol. Sci. 2012, 13  1936 
 
 
Figure 1. Analysis of mitochondrial content and biogenesis (a) Mitochondrial recovery 
was expressed as mg of mitochondrial protein per 10
6 cells. Values are means of seven 
different experiments (bars represent s.d.), * p < 0.005 compared with HepG2 cultivated in 
the presence of 11 mM glucose; (b) The enzymatic measurement of citrate synthase (CS) 
activity was performed spectrophotometrically on total cell homogenates and expressed as 
IU/mg of total protein. Values are means of three different experiments (bars represent 
s.d.), * p < 0.001 compared with HepG2 cultivated in the presence of 11 mM glucose;  
(c) The content of peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) 
was determined by Western blot analysis on total cell homogenates. Different quantities of 
protein were separated by SDS-PAGE, transblotted, and identified with specific antibodies. 
For  quantification  purposes  and  as  loading  control,  a  linear  relationship  was  verified 
between the band intensities (densitometric analysis) and the protein quantities loaded into 
the gel to ensure non-saturating conditions and high reproducibility. Values were inferred 
on the basis of the slope of the straight line and are means of three different experiments 
(bars  represent  s.d.),  *  p  <  0.05  compared  with  HepG2  cultivated  in  the  presence  of  
11 mM glucose taken as 100%. 
 
2.2. Oxygen Consumption in Intact Cells 
Oxygen consumption was determined by high resolution respirometry and representative traces are 
reported in Figure 2a. To evaluate the OXPHOS intrinsic respiratory activity, the respiratory data 
obtained with the oxygraph were normalized to the mitochondrial mass (CS activity). As reported in 
Figure 2b, cultivation in aglycemic conditions (black column) led to a significant increase in all the 
metabolic  states  of  mitochondrial  respiration  (R,  R-L  and  E),  indicating  that  the  entire  OXPHOS 
system  was  up-regulated  upon  the  cells’  adaptation  to  glucose-deprivation.  Also,  this  adaptation 
occurred in excess of the increase of mitochondrial content, and probably involved OXPHOS complex 
synthesis or activity regulation. In particular, based on the increased value of R-L, which represents the 
fraction of respiration actually used for ATP production, the data suggest that cells increased their Int. J. Mol. Sci. 2012, 13  1937 
 
 
mitochondrial  ATP  production  to  survive,  in  accordance  with  Marroquin  et  al.  [18].  Notably,  no 
changes  in  the  respiratory  flux  control  ratios  (R/E,  L/E  and  (R-L)/E)  were  observed  (Figure  2c), 
indicating that OXPHOS increased the production of ATP without improving the efficiency of the 
system. These data are in accordance with a recent report that used the HTB 126 breast carcinoma cell 
line cultivated in aglycemic conditions [6].  
Figure 2. Analysis of oxygen consumption in intact cells. Intact cells were analyzed in 
complete medium as described in the Methods. (a) Representative recordings of oxygen 
concentration [nmol/mL] (blue line) and oxygen flow [pmol/(s ×  10
6)] (red line) measured 
by high resolution respirometry and corrected for instrumental background consumption. 
Abbreviations  denote inhibitors and uncoupler added  into the chamber (O-Oligomycin,  
F-FCCP, R-Rotenone, AA-Antimycin A) at the concentrations specified in the Materials 
and Methods; (b) Respiratory data [pmol/(s ×  10
6)], corrected for the rotenone/antimycin A 
insensitive  respiration,  were  normalized  to  the  mitochondrial  mass  expressed  as  CS  
activity  (IU/10
6  cells).  Metabolic  states:  R-Routine,  L-Proton  Leak  (calculated  as  the  
oligomycin-insensitive  respiratory  rate),  R-L  (calculated  as  the  difference  between  the 
routine and the leak respiration), E-Maximum electron transport system (ETS) capacity 
(calculated as the maximal respiratory rate in the presence of FCCP). Values are means of 
three  different  experiments  (bars  represent  s.d.),  *  p  <  0.05  compared  with  HepG2 
cultivated in the presence of 11 mM glucose; (c) Normalized respiratory flux control ratios: 
R/E ratio was calculated as the routine respiration (R) over the maximum ETS capacity (E); 
L/E was calculated as the leak respiration (L) over the maximum ETS capacity (E); and (R-
L)/E gives the fraction of respiration vs. the maximum ETS capacity that is used under 
routine conditions to produces ATP, referred to as phosphorylating respiration. Values are 
means  of  three  different  experiments  (bars  represent  s.d.),  *  p  <  0.05  compared  with 
HepG2 cultivated in the presence of 11 mM glucose.  
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On the other hand, cultivation in 25 mM glucose (white column) led to a marked increase in proton 
leak  (L)—measured  as  oligomycin–insensitive  respiration,  and  in  the  ratio  of  proton  leak  to  
FCCP-uncoupled respiration (L/E)—as compared with that seen in 11 mM glucose. Strikingly, no 
significant  change  in  phosphorylating  respiration  (R-L)/E  was  observed,  documenting  that  the 
observed increase in routine respiration (R) occurred to compensate for the increase in uncoupling (L). 
A more extensive proton leak might be explained by a difference in membrane composition or as the 
consequence of an increase in the expression of proteins involved in the matrix return of the protons. 
In this regard, more investigations should be carried out. The uncoupling protein isoform 2 (UCP2) is 
also worth mentioning as it is an inner mitochondrial membrane protein which contributes to the 
regulation of the mitochondrial membrane potential and has been found to be overexpressed in various 
cancer cell lines and in primary human colon cancer [19]. Thus, it could therefore account for an 
increase in proton leak in such cells. 
Finally,  the  protocol  used  also  allowed  us  to  evaluate  the  rate  of  non  mitochondrial  oxygen 
consumption as the residual respiration in the presence of rotenone and antimycin A (Table 1). It is 
interesting that this rate was very high in the hyperglycemic condition, in accordance with the finding 
by Herst and Berridge that highly glycolytic tumor cells use trans-plasma membrane electron transport 
(tPMET) to alleviate intracellular reductive stress, and in line with their hypothesis that cell surface 
oxygen consumption via tPMET may support glycolytic energy metabolism by re-oxidizing cytosolic 
NADH to facilitate continued glycolysis [20]. Conversely, in aglycemia, the non mitochondrial oxygen 
consumption was lower and accounted for 14.9% of the total respiration, as was expected on the basis 
of the up-regulation of mitochondria biogenesis and of the OXPHOS system that occurred in this condition. 
Table 1. Non mitochondrial vs. mitochondrial oxygen consumption. The rate of oxygen 
consumption was detected in intact cells under condition of physiological substrate supply 
referred to as routine respiration (R). Measurements were performed in the presence of  
1  µ M  rotenone  and  2.5  µ M  antimycin  A  to  determine  the  non  mitochondrial  oxygen 
consumption and this rate was subtracted from that of total oxygen consumption to assess 
the mitochondrial respiration. Values are expressed as [pmol/(s ×  10
6)] and are means ±  s.d. 
of three different experiments; * p < 0.05 compared with HepG2 cultivated in the presence 
of 10 mM galactose. 
 
Total  
O2 Consumption 
Mitochondrial  
O2 Consumption 
Non Mitochondrial O2 
Consumption 
25 mM Glucose  73.3 ±  11.7 (100%) *  41.1 ±  5.5 (56.2%) *  32.1 ±  6.5 (43.8%) * 
10 mM Galactose  107.7 ±  24.6 (100%)  91.7 ±  17.2 (85.1%)  16 ±  7.8 (14.9%) 
2.3. Expression Levels of Complex II, ATP Synthase and Inhibitor Factor 1 
Expression levels of the Fp subunit of Complex II, the β subunit of ATP synthase, and its natural 
Inhibitor Factor 1 (IF1) were examined by quantitative Western blot analysis on crude mitochondrial 
fractions isolated from HepG2 grown in different glucose concentrations (Figure 3a). The levels of 
these  proteins  were  determined  under  non–saturating  antibody  conditions  and  the  results  were 
summarized in the histograms reported in Figure 3b. Int. J. Mol. Sci. 2012, 13  1939 
 
 
Figure 3. Analysis of Complex II, ATP synthase and Inhibitor Factor 1 (IF1) expression 
level (a) Typical appearance of the immunoreactive bands for the Fp subunit of Complex II, 
the β subunit of ATP synthase, and IF1 obtained by Western blotting mitochondria from 
HepG2 cultivated in different glucose concentration; (b) Expression levels (%) of Complex 
II, ATP synthase, and IF1 in mitochondria from HepG2 cultivated in high and no glucose 
conditions compared to the expression levels detected in cells grown in 11 mM glucose, 
considered  as  100%.  For  quantification  purposes  and  as  loading  control,  a  linear 
relationship  was  verified  between  the  band  intensities  (densitometric  analysis)  and  the 
protein  quantities  loaded  into  the  gel  to  ensure  non-saturating  conditions  and  high 
reproducibility. Values were inferred on the basis of the slope of the straight line and are 
means of three different experiments (bars represent s.d.); * p < 0.05. 
 
HepG2 cultivated in the absence of glucose showed a significant increase in the expression levels  
of Fp-Complex II (+36.5%), β-ATP synthase (+111.4%), and IF1 (+53.8%), demonstrating that the 
improvement of the respiratory capacity observed, resulted from the induction of OXPHOS protein 
expression, in agreement with previous studies [5,6]. 
Strikingly, under high glucose conditions, only the IF1 expression level increased (+72.2%), while 
the expression of Fp-Complex II and β-ATP synthase remained unchanged with respect to levels seen 
in 11 mM glucose. The different response of ATP synthase and IF1 throughout cell adaptation to an 
increase in glucose availability, suggests that the expression of the two proteins may be regulated by 
different  and  independent  pathways,  even  if  the  proteins  are  structurally  and  functionally  closely 
related. IF1 is a well known reversible non competitive inhibitor of ATP synthase that arrests the 
functioning  of  the  enzyme  when  the  mitochondrial  membrane  potential  drops  [21],  playing  an 
important role in tissue ischemia pathology by helping to conserve ATP under conditions of oxygen 
deprivation. Moreover, it was recently reported that IF1 is able to stabilize the oligomeric forms of Int. J. Mol. Sci. 2012, 13  1940 
 
 
ATP synthase [22], which can, in turn, determine mitochondrial cristae shapes [23]. For this reason, 
we further evaluated whether the increase in IF1 expression levels, observed during hyperglycemia, 
correlated with an improvement in oligomer stability. 
2.4. Supramolecular Organization of Mitochondrial ATP Synthase in Membranes 
To  investigate  whether  the  supramolecular  organization  of  ATP  synthase  was  affected  by  the 
bioenergetic  adaptation  of  mitochondria  and  whether  the  increase  in  IF1  expression  level  was 
correlated with ATP synthase oligomer stability, we used BNE to analyze mitochondria isolated from 
HepG2  cultured  in  different  substrates.  Detergent  extraction  of  mitochondria  was  performed  with 
digitonin under controlled conditions, due to its ability to maintain the weak interactions stabilizing 
dimeric/oligomeric interfaces [24]. Considering that the efficacy of the extraction and the amount of 
native monomeric and oligomeric ATP synthase resolved by BNE depends on the concentration of 
detergent  used  for  extraction,  we  carefully  titrated  the  digitonin  in  order  to  identify  the  optimal 
concentration  of  the  digitonin  to  protein  ratio  for  each  condition  investigated.  A  representative 
example  of  digitonin  titration  on mitochondria  isolated  from  HepG2  grown  in  25  mM  glucose  is 
reported in Figure 4a. The dimeric form (Vd) only appeared in gels stained for ATPase activity using  
2 µ g of digitonin per µ g of mitochondrial protein. This digitonin concentration was also verified as 
being that which allowed the better extraction of the dimeric form under the other conditions and was 
routinely  used.  Unfortunately,  higher  oligomers  were  not  resolved  by  BNE,  irrespective  of  the 
digitonin concentration used. We therefore considered the dimer/monomer ratio (Vd/Vm) to be an 
index of the stability of ATP synthase oligomers. 
Figure 4 (panel b and c) shows the results of two-dimensional immunoblotting quantitative analysis 
of ATP synthase monomers and dimers, resolved by BNE, of digitonized mitochondria from cells 
grown under different glucose conditions. The first-dimension native gel was stained with Coomassie 
blue  (panel  b,  left);  bands  assignment  was  performed  by  in-gel  development  of  ATPase  activity  
(panel  b,  right).  BNE  lanes  were  then  subjected  to  a  second-dimension  SDS-PAGE,  followed  by 
immunoblotting of the β subunit (Figure 4c).  
The densitometric analysis, reported in the histogram in Figure 4d, showed that the supramolecular 
organization of ATP synthase in HepG2 cultivated under high glucose condition was markedly worse 
compared to the cells cultivated in aglycemia, as indicated by lower dimer stability. The dimer/monomer 
ratio (Vd/Vm), normalized per mg of extracted protein, was 2.7 ±  0.07 for HepG2 grown in 25 mM 
glucose and 28 ±  3.5 for HepG2 grown in 10 mM galactose.  
These  results  contrast  with  those  obtained  by  Campanella  et  al.  [22],  who  used  a  molecular 
approach, and allow us to exclude the possibility that IF1 plays a role in the stabilization of ATP 
synthase dimers in our model, as the degree of IF1 over-expression was greater in HepG2 cultured in 
25 mM glucose than in aglycemic conditions. Int. J. Mol. Sci. 2012, 13  1941 
 
 
Figure 4. Two-dimensional analysis of monomeric and dimeric forms of ATP synthase 
and  mitochondrial  network  morphology  in  HepG2  grown  in  different  glucose 
concentrations  (a)  Aliquots  of  mitochondria  isolated  from  HepG2  grown  in  DMEM 
containing 25 mM glucose were treated with the indicated concentrations of digitonin (1, 2, 
3, 4 µ g/µ g, dig/prot) and analyzed by BNE Coomassie-stained (left) or stained for in-gel 
ATPase  activity  (o/n  incubation).  BHM:  bovine  heart  mitochondria  extract  used  as  a 
standard, Vd: dimeric form of ATP  synthase, Vm:  monomeric form of ATP synthase; 
(b) Mitochondrial  extracts  (optimal  concentration  of  digitonin  2  µ g/µ g,  dig/prot)  from 
HepG2 grown in 25 mM glucose (A), 11 mM glucose (B), and 10 mM galactose (C) were 
analyzed  by  BNE  Coomassie-stained  (left)  or  stained  for  in-gel  ATPase  activity  (o/n 
incubation).  The  BNE  gel  was  cut  before  activity  staining  in  order  to  avoid  substrate 
limitation due to the marked differences in the amounts of dimer and monomer resolved by 
BNE;  (c)  Monomer  and  dimer  separation  was  achieved  by  1D  BNE  followed  by  2D  
SDS-PAGE of the single lanes. 2D gels were blotted onto nitrocellulose membrane and 
then exposed to a monoclonal antibody specific for the β subunit of ATP synthase complex; 
(d) Densitometric analysis of the immunoreactive bands of 2D immunoblotting. The ratio 
between dimeric and monomeric forms of ATP synthase (Vd/Vm) was normalized per mg 
of protein in the detergent-extract loaded onto the gel. Values are means of three different 
experiments  (bars  represent  s.d.);  *  p  <  0.05  compared  with  HepG2  cultivated  in  the 
presence of 11 mM glucose; (e) Mitochondrial network morphology of HepG2 cultivated 
in the presence of 25 mM glucose or 11  mM glucose. Confocal images are  from one 
experiment representative of five. 
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On  the  other  hand,  we  can  conclude  that  the  energy  substrate  modulates  the  supramolecular 
organization of ATP synthase, as it does for the mitochondrial structure. Indeed, in accordance with 
the  paper that first documented  an  increase  in the mitochondrial network  in  cancer cells  cultured  
in  aglycemic  conditions  [5],  Plecita-Hlavata  et  al.  have  clearly  demonstrated  using  4Pi  confocal 
microscopy that the mitochondrial network morphology in HepG2 is influenced by the energetic status 
induced by culture conditions, with mitochondria undergoing rapid fragmentation upon their exposure 
to  high  glucose  [7].  This  may  be  a  result  of  prolonged  reactive  oxygen  species  production  [25].  
To  verify  the  influence  that  glucose  availability  has  upon  mitochondrial  morphology  under  our 
experimental conditions and relate it to the effect elicited upon the supramolecular organization of 
ATP synthase, we examined cells by fluorescence confocal microscopy using the mitochondrial probe 
Mitotracker Red. In HepG2 cells grown in glucose medium mitochondria appears as a reticulum, 
mostly  clustered  with  bulkier  and  more  spherical  tubules,  in  contrast  to  the  reticulum  in  
galactose-grown cells that appeared to be more interconnected and ramified (Figure 4e). Thus, it is not 
unrealistic  to  link  the  alteration  of  the  mitochondrial  network  with  the  marked  alteration  of  the 
supramolecular organization of ATP synthase (very low Vd/Vm), shown here under the high glucose 
condition. We can also hypothesize that the high Vd/Vm ratio observed in aglycemia may be related to 
a  better  morphology  of  the  mitochondrial  network.  Indeed,  several  lines  of  evidence  suggest  a 
prominent role of ATP synthase in the maintenance of mitochondrial morphology. The cone-shape of 
the assembled ATP synthase oligomers was proposed to explain the curvature of the inner membrane 
cristae,  and  the  deletion  of  subunits,  mediating  oligomeric  interactions,  was  found  to  provoke 
significant alterations to mitochondrial ultrastructure and morphology, with mitochondrial filaments 
appearing partially fragmented [26]. 
It  should  be  emphasized  that  few  studies  exist  in  the  literature  that  concern  ATP  synthase 
supramolecular organization within the mitochondrial membrane of tumor cells. Nevertheless, they 
provide  important  evidence  indicating  that  this  organization  may  be  influenced  by  oncogenic 
transformation. Based on 2D electrophoresis analysis, a strong reduction in ATP synthase oligomers 
was  reported  in  transformed  fibroblasts  compared  to  normal  cells  [27].  Furthermore,  we  recently 
documented that the Vd/Vm ratio observed in an undifferentiated HCC cell line is lower than that seen 
in HepG2, which are partially differentiated [13], suggesting a link between the acquisition of the low 
differentiation-phenotype of HCC and the destabilization of ATP synthase oligomers. 
In this context, the results reported in the present paper support the idea that factors destabilizing 
ATP synthase supramolecular organization may participate in the metabolic adaptation of tumor cells 
to hyperglycemia. Further future investigations are required to verify whether or not modifications of 
both lipids (e.g., cardiolipin) and proteins (e.g., cyclophilin D or ATP synthase subunits), possibly 
involved in the stabilization of the oligomers, may occur as a consequence of metabolic adaptation as 
well as high-glucose-dependent oxidative stress to mitochondria [17]. 
2.5. Proteomic and Functional Analysis of IF1 Association with ATP Synthase 
An oncogenic role of the deregulated expression of IF1 in cancer was recently documented [16], 
and  is  also  suggested  by  the  possibility  that  the  hypoxia-inducible  factor-1α  (HIF-1α),  a  key 
transcriptional factor that controls crucial features of cancer biology, including angiogenesis, glucose Int. J. Mol. Sci. 2012, 13  1943 
 
 
metabolism, cell proliferation and invasion [28], may induce an increase in IF1 protein expression in 
cancer, as it does in a model of acute hypoxia in vitro [29]. Moreover, IF1 may participate in the 
regulation of tumor cell energetic metabolism by controlling ATP production by mitochondrial ATP 
synthase and mediating the shift of cancer cells to a state of enhanced aerobic glycolysis [16]. We 
therefore  investigated  whether  HepG2  adaptation  to  different  glucose  availability  affected  the 
association of IF1 with ATP synthase. 
To establish the state of the association of IF1 with ATP synthase, ATP synthase-enriched digitonin 
extracts from mitochondrial fractions were subjected to a very sensitive immunocapture procedure [30] 
with  the  anti-complex  V  antibody  able  to  precipitate  the  complex  and  associated  proteins. 
Quantification was performed by SDS-PAGE and immunodetection with antibodies recognizing IF1 
and the β subunit of ATP synthase as a measure of the complex. Figure 5a shows that no change in the 
IF1/β ratio was observed in the hyperglycemic condition, indicating that the increase observed in the 
expression level of IF1 was not correlated with a higher association of the ATP synthase complex. On 
the contrary, the IF1/β ratio was significantly reduced in the aglycemic condition, indicating a lower 
degree of enzyme regulation by the inhibitor, despite the increase observed in the expression level of 
IF1, and in accordance with the finding that such an increase was lower compared with the increase in 
β-ATP synthase.  
Moreover,  to  validate  the  immunoprecipitation  data,  the  maximal  hydrolytic  activity  of  ATP 
synthase was measured under activated conditions (i.e., after inducing IF1 release from the complex 
with  a  high  saline  concentration  and  alkaline  pH)  and  compared  with  the  control  condition  
(i.e., steady-state of IF1 binding). Considering that the alkaline/high salt treatment removes more than 
95% of bound IF1 [31], the ATPase activity observed in these conditions was taken as the activity of 
IF1-free enzyme and considered as 100%. On this basis, we calculated the ratio of enzyme activity 
between that seen in conditions of steady-state IF1 binding and that of the IF1-free enzyme, expressed 
as a percentage and used to calculate the amount of IF1-inhibited enzyme. In accordance with the 
immunoprecipitation data (Figure 5b), we found the percentage of IF1-inhibited enzyme in HepG2 
grown in 11 mM of glucose to be 23.7%, which was not significantly different to that seen in the 
hyperglycemic  condition  (26.1%).  On  the  contrary,  in  the  aglycemic  condition,  the  amount  of  
IF1-inhibited enzyme was significantly lower at 15.4%. These results confirm that an increase in the 
IF1 expression level does not correlate with a greater degree of IF1 association to the ATP synthase 
complex, either in the aglycemic condition (in which IF1 association is lower), or in highly glycolytic 
cells. Here the steady-state binding of IF1 to ATP synthase is the same as that seen in conditions with 
lower  glucose  availability,  in  line  with  similar  mitochondrial  energy  production  levels  in  the  two 
conditions. The effect of hyperglycemic or aglycemic conditions on conditioning factors (i.e., pH, 
membrane potential, calcium) affecting the binding of IF1 to ATP synthase may be the object of 
further investigations. Int. J. Mol. Sci. 2012, 13  1944 
 
 
Figure 5. Analysis of the association of the inhibitor protein IF1 to ATP synthase. (a) ATP 
synthase-enriched mitochondrial digitonin extracts were subjected to immunoprecipitation 
with anti-complex V antibodies and analyzed for IF1 and the β subunit of the complex by 
immunoblotting. A graphical representation of the IF1/β ratio is shown as  obtained by 
densitometric analysis of the immunoreactive bands. Values are means of three different 
experiments  (bars  represent  s.d.);  *  p  <  0.05  compared  with  HepG2  cultivated  in  the 
presence  of  11  mM  glucose;  (b)  Oligomycin  sensitive  ATPase  activity  (Vmax)  was 
measured on mitochondria permeabilized by osmotic shock after incubation for 35 min at 
37 ° C in alkaline-high salt conditions (IF1-stripped) or in assay buffer (Control). Values 
are means of four different experiments (bars represent s.d.); * p < 0.05 compared with 
HepG2 cultivated in the presence of 11 mM glucose. 
 
3. Experimental Section  
3.1. Cell Culture Conditions  
HepG2 human hepatocarcinoma  cells  were  cultured in  DMEM (Euroclone)  medium containing 
different glucose concentrations (25 mM and 11 mM); as well as in a galactose medium consisting of 
DMEM deprived of glucose (Invitrogen), supplemented with 10 mM galactose. All mediums also 
contained 1 mM pyruvate, 4 mM glutamine, 10% FSC, 100 U/mL penicillin, and 100 µ g/mL streptomycin. 
Whereas  glutamine  is  used  to  produce  ATP  through  OXPHOS,  the  galactose  goes  mainly  to  the 
pentose phosphate pathway. Frozen HepG2 cells, previously grown in 11 mM glucose medium, were 
thawed and grown for 8 days in high glucose or galactose medium and used for experiments when 
approaching 90% confluence. Cells were kept in 5% CO2 at 37 ° C at air saturation. Cell proliferation 
was evaluated daily for 8 days. Doubling time (DT) was calculated from the exponential growth period 
as follows: DT = (T2 − T1)/[ln(cell number at T2/cell number at T1)/ln(2)], where (T2 − T1) is the 
duration of the exponential phase. 
3.2. Determination of Mitochondrial Mass 
Activity  of  the  mitochondrial  matrix  enzyme  citrate  synthase  (CS)  was  assessed  in  cell 
homogenates  to  provide  an  estimate  of  mitochondrial  mass.  CS  activity  was  recorded 
spectrophotometrically at 412 nm using a UV/Vis Spectrophotometer Lambda14 (Perkin-Elmer), as 
previously described [13]. Briefly, a background rate was obtained by adding cells, sonicated in 1 M 
Tris/HCl (pH 8.1), to 1 mM 5,5'-dithiobis-2-nitrobenzoate (DTNB) and 10 mM acetyl-coenzyme A. Int. J. Mol. Sci. 2012, 13  1945 
 
 
This initial rate was subtracted from the rate obtained upon the addition of the substrate (10 mM 
oxaloacetate). Enzyme activities were expressed as IU (µmoles/min) per mg of protein. The yield of 
the crude mitochondria fractions (see below) from cells suspended at 2 ×  10
7 cells/mL was evaluated 
after culturing with different substrates and expressed as mg of mitochondrial protein per 10
6 cells. 
3.3. Polarographic Measurement of Respiration 
Mitochondrial  oxygen  consumption,  measured  in  intact  cells  under  conditions  of  physiological 
substrate  supply,  was  performed  at  37  ° C  using  a  high-resolution  respirometer  Oxygraph  2  k 
(Oroboros instruments, Innsbruck, Austria). Routine respiration (R) was measured in 3 ×  10
6 cells in  
3 mL chambers containing culture medium, while the leak respiration (L) was obtained in the presence 
of oligomycin (2 µ g/mL), which inhibits ATP synthase; consequently, the electron flow reflects the 
energy requirement to compensate the futile circle of proton pumping. The maximal uncoupler–stimulated 
respiratory activity (E), measured in the presence of a concentration of the uncoupler FCCP (carbonyl 
cyanide p-trifuoromethoxy-phenylhydrazone) empirically determined as optimal (2.5 µ M), provides a 
measure  of  the  capacity  of  the  electron  transport  system  (ETS).  1  µ M  rotenone  (which  inhibits 
complex I) and 2.5 µ M antimycin A (which inhibits complex III) were used to determine the non 
mitochondrial oxygen consumption. This rate was subtracted from cell total oxygen consumption to 
assess the mitochondrial respiration. Using ETS capacity as a common basis for the normalization of 
the metabolic states, the R/E ratio reflects the level of mitochondrial activity relative to ETS capacity. 
Correspondingly, the L/E ratio reflects the level of leak respiration relative to the ETS capacity and 
provides an estimate of intrinsic uncoupling. Finally, the fraction of respiration actually used for ATP 
production (phosphorylating  respiration)  is  estimated  as  the  difference  between R/E  and  L/E,  and 
indicated  as  (R-L)/E.  Data  were  digitally  recorded  using  DatLab4  software;  oxygen  flux  was 
calculated as the negative time derivative of the oxygen concentration, cO2(t). A standard correction 
was performed for instrumental background oxygen flux arising from oxygen consumption of the 
oxygen sensor and minimal back-diffusion into the chamber. 
3.4. Preparation of Crude Mitochondria Fractions 
Collected cells were suspended at a concentration of 2 ×  10
7 cells/mL in mitochondria isolation 
buffer containing 250 mM sucrose, 1 mg/mL BSA, 2 mM EDTA (pH 7.4), and protease inhibitor 
cocktail (1:100), and sonicated at ice-cold temperature (5 s bursts were repeated 3 times with 30 s 
intervals). The resultant homogenate was subjected to differential centrifugation: 800 g for 20 min at  
4 ° C. The supernatant was centrifuged at 16,000 g for 20 min at 4 ° C to obtain the crude mitochondrial 
fraction as a pellet. The pellet was resuspended in buffer solution containing 250 mM sucrose, 10 mM 
Tris-HCl, and 0.1 mM EGTA (pH 7.4) and used immediately for enzymatic analysis or stored at  
−80 ° C.  
3.5. Western Blot Analysis of Cell and Mitochondrial Lysates 
The preparation of samples from cell lysates and crude mitochondrial fractions and electrophoresis 
were  performed  as  described  previously  [13]  and  subjected  to  Western  blot  analysis  using  the Int. J. Mol. Sci. 2012, 13  1946 
 
 
following antibodies: mouse monoclonal anti-IF1 (Mitosciences), rabbit polyclonal anti-β subunit of 
ATP synthase (Mitosciences), mouse monoclonal anti-Fp subunit of Complex II (Mitosciences) and 
rabbit  polyclonal  anti-PGC1α  (Abcam).  Densitometric  analysis  was  performed  with  Quantity  One 
4.2.1  software  (Bio-Rad  Hercules,  California).  A  linear  relationship  between  increasing  band 
intensities and the quantities of proteins loaded into the gel was confirmed in each case in order to 
prove  non–saturating  conditions.  Quantitative  data  were  inferred  by  densitometric  analysis  of 
immunoreactive bands on the basis of the slope of the straight line and reported as % of HepG2 grown 
in 11 mM glucose expression level, taken as 100%.  
3.6. 2D-Immunoblotting Analysis with Blue Native Electrophoresis as a First-Dimension 
Pellets of heavy mitochondria from bovine heart (BHM), isolated as described in Tomasetig et al. [32], 
and HepG2 crude mitochondria fractions were suspended at 6.25 mg/mL and 15 mg/mL, respectively, 
in extraction buffer (5 mM aminocaproic acid, 50 mM NaCl, and 30 mM Tris pH 7.4), solubilized with 
different concentrations of digitonin (2.4 µ g/µ g dig/prot for BHM and 1, 2, 3, 4 µ g/µg dig/prot for cell 
mitochondria), and immediately centrifuged at 100,000 g for 25 min at 4 ° C. Titration curves were 
created  to  establish  the  optimal  detergent  amount  to  extract  intact  ATP  synthase  complex  in  its 
monomeric and oligomeric forms. The protein digitonin extracts, quantified using the Bradford method, 
were supplemented with Coomassie Blue G-250 (Serva) and rapidly applied to 4–11% polyacrylamide 
gradient blue native gel (BNE). After electrophoresis, gels were stained with Coomassie Blue or used 
for  in-gel  activity  staining.  Coomassie  Blue-stained  gels  were  quantified  by  densitometry  using 
ImageQuant software, version 2003.03 (Amersham Biosciences). Gel strips from BNE were further 
resolved by two-dimensional SDS-PAGE (17%), followed by Western blotting using anti-β subunit 
antibody (Mitosciences).  
3.7. Confocal Microscopy 
5 ×  10
4 cells were plated in complete medium on glass coverslips and grown overnight. Cells were 
stained  with  the  mitochondrial  marker  Mitotracker  Red  CMXRos  (100  nM)  (Molecular  Probes, 
Eugene, OR, USA) in complete medium. After staining, cells were fixed in medium containing 3.7% 
paraformaldehyde and analysed using a laser scanning confocal microscope equipped with a 488–534 λ 
Ar laser and a 633 λ He-Ne laser (Leica TCSNT, Leica Mycrosystem, Wetzler, Germany). 
3.8. ATP Synthase Immunoprecipitation and IF1 Immunodetection 
Mitochondrial extracts, obtained as described above, were used to immunoprecipitate ATP synthase 
and immunodetect IF1 bound to the enzyme. Aliquots were incubated overnight under wheel rotation 
at 4 ° C in the presence of anti-complex V monoclonal Ab covalently linked to protein G-Agarose beads 
(MS501 immunocapture kit from Mitosciences) in a ratio of 20 µL/mg of protein, as recommended by 
the immunocapture kit supplier. After gentle centrifugation (500 g for 5 min), the beads were washed 
twice for 5 min in a solution of 0.05% (w/v) n-Dodecyl-β-D-maltoside (DDM) in PBS. The elution was 
performed in 2% (w/v) SDS for 15 min, and the collected fractions were subjected to SDS-PAGE, 
followed by Western blotting using anti-β subunit of ATP synthase and anti-IF1 antibodies.  Int. J. Mol. Sci. 2012, 13  1947 
 
 
3.9. Mitochondrial ATP Synthase Activity 
Maximal  ATPase  activity  (Vmax)  of  mitochondrial  ATP  synthase  was  measured  in  an  
ATP-regenerating system at 37 ° C. Mitochondrial membranes obtained by osmotic shock (incubation 
dilution 1:5 for 3 min) were incubated in a medium containing 30 mM sucrose, 50 mM Tris/HCl  
(pH 7.4), 4 mM MgCl2, 50 mM KCl, 2 mM EGTA 2 mM phosphoenolpyruvate, 0.3 mM NADH,  
2 µ g/mL rotenone, 4 IU of pyruvate kinase, and 3 IU of lactate dehydrogenase. The reaction was 
started by the addition of 2.5 mM ATP and the rate of NADH oxidation, equimolar to ATP hydrolysis, 
was monitored as the decrease in absorbance at 340 nm. To induce the release of the inhibitor protein 
IF1 from ATP synthase, the mitochondrial membranes obtained by osmotic shock were incubated for 
35 min at 37 ° C under ―activating conditions‖ consisting of 125 mM KCl, 2 mM EDTA, and 30 mM  
Tris-SO4 (pH 8.5). The ATPase activity sustained by ATP synthase was measured on the basis of its 
sensitivity to 10 µ M oligomycin. Results are reported as IU/mg; one unit was defined as that required 
for the oxidation of 1 µ mol NADH/min/mg. 
3.10. Statistical Analyses 
The results presented correspond to mean values ± standard deviations (s.d.); Student’s t tests were 
used to test for statistically significant differences; p < 0.05 was considered to be statistically significant. 
4. Conclusions 
This work investigated the effects induced on mitochondria by changes in glucose availability in the 
HepG2  hepatocarcinoma  cell  line,  mainly  focusing  on  ATP  synthase  and  Inhibitory  Factor  1. 
Aglycemic culture conditions stimulated mitochondrial activity in HepG2 cells as a result of increased 
mitochondrial mass and OXPHOS protein expression levels, demonstrating the OXPHOS system to 
play  an  important  role  in  energy  production  and  cell  viability  under  glucose–limiting  conditions. 
Notably, the regulation of ATP synthase by IF1 was reduced.  
We  demonstrated,  for  the  first  time,  a  hyperglycemia-induced  alteration  in  the  supramolecular 
organization of ATP synthase. We propose this  as the probable cause of the extensively reported 
glucose-induced modulations to mitochondrial morphology [5–7,33]. To our knowledge, the impact of 
metabolic adaptation on the supramolecular organization of ATP synthase has not been previously 
described. Furthermore, we demonstrated a hyperglycemia-induced increase in IF1 expression levels, 
whilst ATP synthase levels remained unaltered. IF1 overexpression in tumor cells has previously been 
documented and linked to the more efficient regulation of ATP synthase [13,16,34]. Surprisingly, in 
our model, an increase in mitochondrial IF1 did not lead to any impairment in the phosphorylation rate 
and  was  not  associated  with  an  increase  in  the  steady-state  binding  of  IF1  to  ATP  synthase.  In 
conclusion, the deregulated expression of IF1 in tumor cells induced by hyperglycemia may exert an 
effect not related to the well known role of IF1 on ATP synthase regulation, or may represent the cells’ 
effort to control ATP synthase activity during stressful conditions (e.g., hypoxia).  
The overall clinical significance of our findings is unclear and requires additional work to improve 
the understanding of the role of hyperglycemia-induced deregulation of IF1 expression and alteration 
in the supramolecular organization of ATP synthase, as well as the role of up-regulated OXPHOS Int. J. Mol. Sci. 2012, 13  1948 
 
 
system in energy production and cell viability under glucose–limiting conditions. Nevertheless, our 
findings provide some new information that may be useful for comprehension of the oncogenic role of 
deregulated IF1 expression (mimicked under hyperglycemic conditions), together with the putative 
oncosuppressor  role  of  mitochondrial  biogenesis  and  ATP  synthase  supramolecular  organization 
(mimicked under aglycemic conditions) in relation to the understanding of cancer metabolic adaptation 
and the development of future targeted therapeutic strategies. 
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